$AEVA Cashflow Statement | Understand Stock

$AEVA

$10.37 +$0.46 (4.64%) Live

$AEVA Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated statements of cash flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Cash flows from operating activities:
Net loss
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization
Impairment of inventories
Loss on joint development agreement (2)
Loss on write down of fixed assets
Fair value at issuance of Series A warrants
Change in fair value of warrant liabilities
Stock-based compensation
Amortization of right-of-use assets
Realized loss on available-for-sale securities
Amortization of premium and accretion of discount on available-for-sale securities, net
Other
Changes in operating assets and liabilities:
Accounts receivable, net
Inventories
Other current assets
Other noncurrent assets
Accounts payable
Accrued liabilities
Accrued employee costs
Lease liability
Other current liabilities
Other noncurrent liabilities
Net cash used in operating activities

Cash flows from investing activities:
Purchase of property, plant, and equipment (including advance)
Purchase of non-marketable equity investments
Purchase of available-for-sale securities
Proceeds from sale of available-for-sale securities
Proceeds from maturities of available-for-sale securities
Purchase of intangible assets
Net cash provided by investing activities
Cash flows from financing activities:
Proceeds from business combination and private offering
Proceeds from issuance of stock in private placement
Transaction costs related to business combination and private offering
Transaction costs related to issuance of stock in private placement
Proceeds from convertible notes
Transaction costs related to convertible notes
Payments of taxes withheld on net settled vesting of restricted stock units
Proceeds from the issuance of Series B Preferred Stock
Proceeds from exercise of stock options
Proceeds from exercise of warrants
Financing costs incurred
Net cash (used in) provided by financing activities

Net increase (decrease) in cash and cash equivalents
Beginning cash and cash equivalents
Ending cash and cash equivalents
Supplemental disclosures of cash flow information:
Cash paid for interest
Cash paid for income taxes
Supplemental disclosure of noncash investing and financing activities:
Unpaid property, plant and equipment purchases
Joint development contract assets
Convertible debt issuance cost included in accounts payable
Private placement of warrants acquired as part of merger
Right-of-use asset obtained in exchange for lease liability
Non-cash lease adoption

Comments